Lead identification to clinical candidate selection: drugs for Chagas disease (Q35301205)

7 August 2017

Lead identification to clinical candidate selection: drugs for Chagas disease (English)

1 reference

7 August 2017

0 references

Alejandra Gallardo-Godoy

object named as

Alejandra Gallardo-Godoy

8

0 references

Jair Siqueira-Neto

object named as

Jair L Siqueira-Neto

19

0 references

James H McKerrow

18

object named as

James McKerrow

1 reference

7 August 2017

R Jeffrey Neitz

1

1 reference

7 August 2017

Steven Chen

2

1 reference

7 August 2017

Frantisek Supek

3

1 reference

7 August 2017

Vince Yeh

4

1 reference

7 August 2017

Danielle Kellar

5

1 reference

7 August 2017

Jiri Gut

6

1 reference

7 August 2017

Clifford Bryant

7

1 reference

7 August 2017

Valentina Molteni

9

1 reference

7 August 2017

Steven L Roach

10

1 reference

7 August 2017

Shilpi Khare

11

1 reference

7 August 2017

Monique Stinson

12

1 reference

7 August 2017

Arnab K Chatterjee

13

1 reference

7 August 2017

Stephanie Robertson

14

1 reference

7 August 2017

Adam R Renslo

15

1 reference

7 August 2017

Michelle Arkin

16

1 reference

7 August 2017

Richard Glynne

17

1 reference

7 August 2017

3 October 2014

1 reference

Journal of Biomolecular Screening

7 August 2017

1 reference

7 August 2017

20

1 reference

7 August 2017

101-111

1 reference

7 August 2017

1

1 reference

Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem

7 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Chagas disease: a new worldwide challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Chagas disease: "the new HIV/AIDS of the Americas"

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Safety of benznidazole use in the treatment of chronic Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

A modern in vivo pharmacokinetic paradigm: combining snapshot, rapid and full PK approaches to optimize and expedite early drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Development and application of high throughput plasma stability assay for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Two analogues of fenarimol show curative activity in an experimental model of Chagas disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

Data, information, knowledge and principle: back to metabolism in KEGG

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

An Estimate of the Burden of Chagas Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114553103

21 January 2018

Identifiers

DOI

10.1177/1087057114553103

1 reference

7 August 2017

1 reference